<DOC>
	<DOCNO>NCT02420132</DOCNO>
	<brief_summary>Study Evaluate Home Vision Testing Patients Receiving Ranibizumab</brief_summary>
	<brief_title>Study Evaluate Home Vision Testing Patients Receiving Ranibizumab</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Diabetic Macular Edema ( DME ) active neovascular agerelated Macular Degeneration ( nAMD ) least one eye Current treatment intravitreal LucentisÂ® therapy , evaluation plan every 4 8 week Best correct visual acuity ( Snellen assess glass and/or contact lens ) 20/100 good study eye , potential vision recovery standardofcare treatment Age &gt; = 18 year Access approve mobile device data plan WiFi internet access Any eye condition cause eye disease limit vision correct , Diabetic Macular Edema ( DME ) neovascular agerelated Macular Degeneration ( nAMD ) . Dementia neurologic psychological limitation would prevent patient perform regular selftesting visual function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>